Clinical and experimental medicineHumansCarcinomaRenal CellImmunotherapyKidney Neoplasms
Immunotherapy in clear cell renal cell carcinoma: current Status, novel Strategies, and future perspectives.
Xiaoli Chen, Yasi Ke, Xuehong Huang, Jialin Chen, Jianan Chen, Zhiyao Chen
Published: 202610.1007/s10238-025-02031-0
Abstract
Clear cell renal cell carcinoma (ccRCC) remains a major clinical challenge, with high rates of recurrence and limited long-term survival despite surgical resection and VEGF-targeted therapy. Immune checkpoint inhibitors (ICIs)-targeting PD-1, PD-L1,…
Preview only. Read the full abstract at the source